PatenSee

medical devices

About

PatenSee is a clinical-stage medical device company that has developed a contactless surveillance system designed to detect early developing asymptomatic vascular stenosis in hemodialysis patients. By harnessing advanced, multi-modal imaging technologies and Machine Learning, PatenSee's aims to flag stenosis risk at the earliest stage, enabling care teams to perform simple interventions to protect the patient's hemodialysis lifeline, improve quality of care and prolong life expectancy. PatenSee addresses the dialysis market, which is expected to exceed $100B by 2024. PatenSee is a seed stage portfolio company of MEDX Xelerator. PatenSee was founded by Hagay Drori and Oz Seadia following their participation in MEDX Xelerator's X-Challenge competition, the incubator's initiative to create promising medical device startups. Dr. Gal Goshen, PatenSee's CEO, led it from early concept to first-in-human clinical study in less than two years.

Technologies

Outlook Mobile Friendly WordPress.org

Keywords

esdr hemodialysis vascular access stenosis bloodflow preventative care machinelearning renal care medtech innovation medical device medical equipment manufacturing telehealth kdoki guidelines compliance early intervention ai diagnostics clinical-stage medical device early detection optical imaging healthcare technology patient safety enhancement biomedical imaging b2b objective assessment fresenius collaboration non-invasive vascular monitoring clinical trial expansion machine learning automated detection medical device incubator vascular health

Location

407 E Fort St, Detroit, Michigan, United States, 48226-2916

Related Companies

Companies in the same industry